David Pace

Summary

Publications

  1. doi request reprint Glycoconjugate vaccines
    David Pace
    Mater Dei Hospital, Department of Paediatrics, Msida, Malta
    Expert Opin Biol Ther 13:11-33. 2013
  2. doi request reprint Meningococcal disease: clinical presentation and sequelae
    David Pace
    Department of Paediatrics, Mater Dei Hospital, Tal Qroqq, Msida, MSD 2090, Malta
    Vaccine 30:B3-9. 2012
  3. pmc Manifestations of paediatric Leishmania infantum infections in Malta
    David Pace
    Paediatric Infectious Diseases Clinic, Mater Dei Hospital, Msida, Malta
    Travel Med Infect Dis 9:37-46. 2011
  4. doi request reprint Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults
    David Pace
    Department of Paediatrics, Mater Dei Hospital, Tal Qroqq, Msida, Malta
    Future Microbiol 5:1629-40. 2010
  5. doi request reprint Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy
    David Pace
    Department of Paediatrics, Mater Dei Hospital, Tal Qroqq, Msida, Malta
    Expert Rev Vaccines 8:529-42. 2009
  6. doi request reprint Epidemiology of pathogenic Neisseria meningitidis serogroup B serosubtypes in Malta: implications for introducing PorA based vaccines
    David Pace
    Department of Paediatrics, Mater Dei Hospital, MSD, Malta
    Vaccine 26:5952-6. 2008
  7. doi request reprint Quadrivalent meningococcal conjugate vaccines
    David Pace
    Department of Paediatrics, Mater Dei Hospital, Tal Qroqq, Msida, MSD 2090, Malta
    Vaccine 27:B30-41. 2009
  8. ncbi request reprint MenACWY-CRM, a novel quadrivalent glycoconjugate vaccine against Neisseria meningitidis for the prevention of meningococcal infection
    David Pace
    Mater Dei Hospital, Department of Paediatrics, Tal Qroqq, Msida, MSD 2090, Malta
    Curr Opin Mol Ther 11:692-706. 2009
  9. doi request reprint Adequacy of pediatric triage
    Pharrah Debono
    Department of Paediatrics, Mater Dei Hospital, Tal Qroqq, Msida, Malta
    Disaster Med Public Health Prep 6:151-4. 2012
  10. doi request reprint Quest for the diagnosis. Case 1: a neonatal zoonosis. Neonatal Pasteurella multocida septicaemia
    David Pace
    Department of Paediatrics, St Luke s Hospital, Guardamangia, Malta
    Acta Paediatr 97:250-2. 2008

Collaborators

  • Pharrah Debono
  • Juanita Debattista
  • Simon Attard-Montalto

Detail Information

Publications10

  1. doi request reprint Glycoconjugate vaccines
    David Pace
    Mater Dei Hospital, Department of Paediatrics, Msida, Malta
    Expert Opin Biol Ther 13:11-33. 2013
    ..The limitations of plain polysaccharide vaccines make immunisation with glycoconjugates a more sustainable long term option...
  2. doi request reprint Meningococcal disease: clinical presentation and sequelae
    David Pace
    Department of Paediatrics, Mater Dei Hospital, Tal Qroqq, Msida, MSD 2090, Malta
    Vaccine 30:B3-9. 2012
    ..The only rational approach to the prevention of meningococcal disease and the associated human suffering is through vaccination...
  3. pmc Manifestations of paediatric Leishmania infantum infections in Malta
    David Pace
    Paediatric Infectious Diseases Clinic, Mater Dei Hospital, Msida, Malta
    Travel Med Infect Dis 9:37-46. 2011
    ..Leishmaniasis should be included in the differential diagnosis of fever and hepatosplenomegaly or chronic cutaneous lesions in children who travel to Malta...
  4. doi request reprint Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults
    David Pace
    Department of Paediatrics, Mater Dei Hospital, Tal Qroqq, Msida, Malta
    Future Microbiol 5:1629-40. 2010
    ..In Europe, MenACWY-CRM is the first quadrivalent meningococcal glycoconjugate vaccine available to provide broader protection against Neisseria meningitidis serogroups A, C, W-135 and Y...
  5. doi request reprint Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy
    David Pace
    Department of Paediatrics, Mater Dei Hospital, Tal Qroqq, Msida, Malta
    Expert Rev Vaccines 8:529-42. 2009
    ..This article discusses this novel quadrivalent vaccine formulation and its potential to control invasive disease caused by N. meningitidis serogroups A, C, Y and W-135...
  6. doi request reprint Epidemiology of pathogenic Neisseria meningitidis serogroup B serosubtypes in Malta: implications for introducing PorA based vaccines
    David Pace
    Department of Paediatrics, Mater Dei Hospital, MSD, Malta
    Vaccine 26:5952-6. 2008
    ....
  7. doi request reprint Quadrivalent meningococcal conjugate vaccines
    David Pace
    Department of Paediatrics, Mater Dei Hospital, Tal Qroqq, Msida, MSD 2090, Malta
    Vaccine 27:B30-41. 2009
    ..This vaccine and others in development offer the potential to broaden population protection against meningococcal disease...
  8. ncbi request reprint MenACWY-CRM, a novel quadrivalent glycoconjugate vaccine against Neisseria meningitidis for the prevention of meningococcal infection
    David Pace
    Mater Dei Hospital, Department of Paediatrics, Tal Qroqq, Msida, MSD 2090, Malta
    Curr Opin Mol Ther 11:692-706. 2009
    ....
  9. doi request reprint Adequacy of pediatric triage
    Pharrah Debono
    Department of Paediatrics, Mater Dei Hospital, Tal Qroqq, Msida, Malta
    Disaster Med Public Health Prep 6:151-4. 2012
    ..To assess the adequacy of the pediatric triage system in an acute care general hospital...
  10. doi request reprint Quest for the diagnosis. Case 1: a neonatal zoonosis. Neonatal Pasteurella multocida septicaemia
    David Pace
    Department of Paediatrics, St Luke s Hospital, Guardamangia, Malta
    Acta Paediatr 97:250-2. 2008